American Century Companies Inc Pmv Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$1.51 - $2.21 $232 - $340	154 Added 0.31%	50,241 $81,000
Q1 2024 May 14, 2024	BUY	$1.51 - $3.12 $8,212 - $16,969	5,439 Added 12.18%	50,087 $85,000
Q4 2023 Feb 13, 2024	BUY	$1.23 - $6.6 $54,917 - $294,676	44,648 New	44,648 $138,000
Q3 2023 Nov 13, 2023	BUY	$6.01 - $8.93 $48,957 - $72,743	8,146 Added 39.42%	28,811 $176,000
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $81,420 - $129,569	20,665 New	20,665 $129,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.